BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9422555)

  • 1. Effect of time, dose, and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma.
    Lee AW; Foo W; Chappell R; Fowler JF; Sze WM; Poon YF; Law SC; Ng SH; O SK; Tung SY; Lau WH; Ho JH
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):35-42. PubMed ID: 9422555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment time.
    Lee AW; Kwong DL; Leung SF; Tung SY; Sze WM; Sham JS; Teo PM; Leung TW; Wu PM; Chappell R; Peters LJ; Fowler JF
    Int J Radiat Oncol Biol Phys; 2002 May; 53(1):75-85. PubMed ID: 12007944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dosimetric factors on occurrence and volume of temporal lobe necrosis following intensity modulated radiation therapy for nasopharyngeal carcinoma: a case-control study.
    Zhou X; Ou X; Xu T; Wang X; Shen C; Ding J; Hu C
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):261-9. PubMed ID: 25066214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-Infiltrating T Cell Receptor-Beta Repertoires are Linked to the Risk of Late Chemoradiation-Induced Temporal Lobe Necrosis in Locally Advanced Nasopharyngeal Carcinoma.
    Wu L; Chung YL
    Int J Radiat Oncol Biol Phys; 2019 May; 104(1):165-176. PubMed ID: 30654091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reirradiation for recurrent nasopharyngeal carcinoma: factors affecting the therapeutic ratio and ways for improvement.
    Lee AW; Foo W; Law SC; Poon YF; Sze WM; O SK; Tung SY; Lau WH
    Int J Radiat Oncol Biol Phys; 1997 Apr; 38(1):43-52. PubMed ID: 9212003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of dosimetric factors associated with temporal lobe necrosis (TLN) in patients with nasopharyngeal carcinoma (NPC) after intensity modulated radiotherapy.
    Su SF; Huang SM; Han F; Huang Y; Chen CY; Xiao WW; Sun XM; Lu TX
    Radiat Oncol; 2013 Jan; 8():17. PubMed ID: 23336282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation induced temporal lobe necrosis in nasopharyngeal cancer patients after radical external beam radiotherapy.
    Wu VWC; Tam SY
    Radiat Oncol; 2020 May; 15(1):112. PubMed ID: 32414378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of radiation-induced cerebral vascular injury in nasopharyngeal carcinoma patients with radiation-induced temporal lobe necrosis.
    Ye J; Rong X; Xiang Y; Xing Y; Tang Y
    PLoS One; 2012; 7(8):e42890. PubMed ID: 22912759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric parameters predict radiation-induced temporal lobe necrosis in nasopharyngeal carcinoma patients: A systematic review and meta-analysis.
    Dong J; Ng WT; Wong CHL; Li JS; Bollen H; Chow JCH; Eisbruch A; Lee AWM; Lee VHF; Ng SP; Nuyts S; Smee R; Ferlito A
    Radiother Oncol; 2024 Jun; 195():110258. PubMed ID: 38537680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal Tissue Complication Probability Model for Radiation-induced Temporal Lobe Injury after Intensity-modulated Radiation Therapy for Nasopharyngeal Carcinoma.
    Zeng L; Huang SM; Tian YM; Sun XM; Han F; Lu TX; Deng XW
    Radiology; 2015 Jul; 276(1):243-9. PubMed ID: 25658039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-volume relationships associated with temporal lobe radiation necrosis after skull base proton beam therapy.
    McDonald MW; Linton OR; Calley CS
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):261-7. PubMed ID: 25636754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different risks of symptomatic brain necrosis in NPC patients treated with different altered fractionated radiotherapy techniques.
    Jen YM; Hsu WL; Chen CY; Hwang JM; Chang LP; Lin YS; Su WF; Chen CM; Liu DW; Chao HL
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):344-8. PubMed ID: 11567807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion Kurtosis as an in vivo Imaging Marker of Early Radiation-Induced Changes in Radiation-Induced Temporal Lobe Necrosis in Nasopharyngeal Carcinoma Patients.
    Liyan L; Si W; Qian W; Yuhui S; Xiaoer W; Yuehua L; Wenbin L
    Clin Neuroradiol; 2018 Sep; 28(3):413-420. PubMed ID: 28447147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total biological effect on late reactive tissues following reirradiation for recurrent nasopharyngeal carcinoma.
    Lee AW; Foo W; Law SC; Peters LJ; Poon YF; Chappell R; Sze WM; Tung SY; Lau WH; Ho JH
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):865-72. PubMed ID: 10705007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes of 174 nasopharyngeal carcinoma patients with radiation-induced temporal lobe necrosis.
    Lam TC; Wong FC; Leung TW; Ng SH; Tung SY
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e57-65. PubMed ID: 21300460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications.
    Teo PM; Leung SF; Chan AT; Leung TW; Choi PH; Kwan WH; Lee WY; Chau RM; Yu PK; Johnson PJ
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1311-22. PubMed ID: 11121628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma-patient- and treatment-related risk factors.
    Lee AW; Ng WT; Hung WM; Choi CW; Tung R; Ling YH; Cheng PT; Yau TK; Chang AT; Leung SK; Lee MC; Bentzen SM
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1121-8. PubMed ID: 18723296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical diagnosis of late temporal lobe necrosis following radiation therapy for nasopharyngeal carcinoma.
    Lee AW; Ng SH; Ho JH; Tse VK; Poon YF; Tse CC; Au GK; O SK; Lau WH; Foo WW
    Cancer; 1988 Apr; 61(8):1535-42. PubMed ID: 3349419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of accelerated fractionation versus conventional fractionation for nasopharyngeal carcinoma].
    Wang YM; Wang F; Fu Q; Kong F; Chen XZ
    Ai Zheng; 2008 Dec; 27(12):1283-6. PubMed ID: 19079994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of time, dose and fractionation on local control of nasopharyngeal carcinoma.
    Lee AW; Chan DK; Fowler JF; Poon YF; Foo W; Law SC; O SK; Tung SY; Chappell R
    Radiother Oncol; 1995 Jul; 36(1):24-31. PubMed ID: 8525022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.